Literature DB >> 22850738

Comparisons of CYP2A6 genotype and enzyme activity between Swedes and Koreans.

Natasa Djordjevic1, Juan Antonio Carrillo, Marieke P J van den Broek, Junko Kishikawa, Hyung-Keun Roh, Leif Bertilsson, Eleni Aklillu.   

Abstract

The aim was to compare cytochrome P450 2A6 (CYP2A6) genotype and enzyme activity between Swedes and Koreans, and to investigate the influence of genotype, sex, age, cigarette smoking and oral contraceptive (OC) use on enzyme activity. The study involved 190 Swedes and 144 Koreans. Genotyping for CYP2A6*1B, *1×2, *4, *5, *7, *8, *9, *10, *18 and *19 alleles was done. Using caffeine as a probe, in vivo CYP2A6 activity was estimated by the 17U/17X urinary ratio. Multiple regression analysis indicated ethnicity (p=0.0001) and CYP2A6 genotype (p=0.006), but not sex, age, cigarette smoking or OC use as predictors of CYP2A6 activity. There were significant differences in CYP2A6 genotype distribution and enzyme activity between Swedes and Koreans. Functional CYP2A6 alleles and rapid genotypes were more frequent in Swedes, whereas the defective alleles and slow genotypes were more frequent in Koreans (p≤0.0001). Distribution of log 17U/17X was bimodal in Koreans but unimodal in Swedes with a common antimode at 0.01, classifying 3.16% of Swedes and 18.75% of Koreans as slow metabolizers. CYP2A6 activity was higher in Swedes compared to Koreans (p<0.0001), even among carriers of rapid genotypes. We report major differences in CYP2A6 enzyme activity between Swedes and Koreans mainly due to CYP2A6 genetic variation but not exclusively.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22850738     DOI: 10.2133/dmpk.dmpk-12-rg-029

Source DB:  PubMed          Journal:  Drug Metab Pharmacokinet        ISSN: 1347-4367            Impact factor:   3.614


  7 in total

1.  High CYP2A6 enzyme activity as measured by a caffeine test and unique distribution of CYP2A6 variant alleles in Ethiopian population.

Authors:  Eleni Aklillu; Natasa Djordjevic; Juan Antonio Carrillo; Eyasu Makonnen; Leif Bertilsson; Magnus Ingelman-Sundberg
Journal:  OMICS       Date:  2013-12-31

2.  Biomarkers of tobacco smoke exposure in racial/ethnic groups at high risk for lung cancer.

Authors:  Pebbles Fagan; Eric T Moolchan; Pallav Pokhrel; Thaddeus Herzog; Kevin D Cassel; Ian Pagano; Adrian A Franke; Joseph Keawe'aimoku Kaholokula; Angela Sy; Linda A Alexander; Dennis R Trinidad; Kari-Lyn Sakuma; C Anderson Johnson; Alyssa Antonio; Dorothy Jorgensen; Tania Lynch; Crissy Kawamoto; Mark S Clanton
Journal:  Am J Public Health       Date:  2015-04-16       Impact factor: 9.308

Review 3.  Quantitative Proteomics in Translational Absorption, Distribution, Metabolism, and Excretion and Precision Medicine.

Authors:  Deepak Ahire; Laken Kruger; Sheena Sharma; Vijaya Saradhi Mettu; Abdul Basit; Bhagwat Prasad
Journal:  Pharmacol Rev       Date:  2022-07       Impact factor: 18.923

4.  Intraindividual covariation between e-cigarette and combustible cigarette use in Korean American emerging adults.

Authors:  Jimi Huh; Adam M Leventhal
Journal:  Psychol Addict Behav       Date:  2015-11-30

Review 5.  Variation in CYP2A6 Activity and Personalized Medicine.

Authors:  Julie-Anne Tanner; Rachel F Tyndale
Journal:  J Pers Med       Date:  2017-12-01

Review 6.  Distribution of polymorphic variants of CYP2A6 and their involvement in nicotine addiction.

Authors:  Luis A López-Flores; Gloria Pérez-Rubio; Ramcés Falfán-Valencia
Journal:  EXCLI J       Date:  2017-03-06       Impact factor: 4.068

7.  Impact of Population and Pharmacogenetics Variations on Efavirenz Pharmacokinetics and Immunologic Outcomes During Anti-Tuberculosis Co-Therapy: A Parallel Prospective Cohort Study in Two Sub-Sahara African Populations.

Authors:  Sabina Mugusi; Abiy Habtewold; Eliford Ngaimisi; Wondwossen Amogne; Getnet Yimer; Omary Minzi; Eyasu Makonnen; Christopher Sudfeld; Jürgen Burhenne; Eleni Aklillu
Journal:  Front Pharmacol       Date:  2020-02-07       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.